ReviewFrontiers in immunology2026
Mechanisms of inflammatory cell activation in periodontitis-induced bone destruction and advances in targeted interventions.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Periodontitis is a leading cause of tooth loss in adults, characterized primarily by alveolar bone destruction driven by dysregulated host immune-inflammatory responses. Central to this pathological process is the aberrant activation of inflammatory cells within the periodontal microenvironment. This review comprehensively summarizes the activation phenotypes, functions, and interaction networks of key inflammatory cells including macrophages, neutrophils, T cells, and B cells in periodontitis. It elucidates the molecular and cellular mechanisms by which these activated cells contribute to bone destruction through the release of inflammatory mediators and regulation of osteoclastogenesis and osteoclast function. Furthermore, the review highlights recent advances in targeted therapeutic strategies aimed at modulating inflammatory cell activation, encompassing small molecule inhibitors, biologics, and cell-based therapies. By integrating current knowledge on inflammatory cell dynamics and targeted interventions. This review aims to identify key therapeutic targets within inflammatory cell networks to guide the development of precision therapies for periodontitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.